A citation-based method for searching scientific literature

Marianne Labussière, Blandine Boisselier, Karima Mokhtari, Anna-Luisa Di Stefano, Anais Rahimian, Marta Rossetto, Pietro Ciccarino, Olivier Saulnier, Rosina Paterra, Yannick Marie, Gaetano Finocchiaro, Marc Sanson. Neurology 2014
Times Cited: 123



Cameron W Brennan, Roel G W Verhaak, Aaron McKenna, Benito Campos, Houtan Noushmehr, Sofie R Salama, Siyuan Zheng, Debyani Chakravarty, J Zachary Sanborn, Samuel H Berman, Rameen Beroukhim, Brady Bernard, Chang-Jiun Wu, Giannicola Genovese, Ilya Shmulevich, Jill Barnholtz-Sloan, Lihua Zou, Rahulsimham Vegesna, Sachet A Shukla, Giovanni Ciriello, W K Yung, Wei Zhang, Carrie Sougnez, Tom Mikkelsen, Kenneth Aldape, Darell D Bigner, Erwin G Van Meir, Michael Prados, Andrew Sloan, Keith L Black, Jennifer Eschbacher, Gaetano Finocchiaro, William Friedman, David W Andrews, Abhijit Guha, Mary Iacocca, Brian P O'Neill, Greg Foltz, Jerome Myers, Daniel J Weisenberger, Robert Penny, Raju Kucherlapati, Charles M Perou, D Neil Hayes, Richard Gibbs, Marco Marra, Gordon B Mills, Eric Lander, Paul Spellman, Richard Wilson, Chris Sander, John Weinstein, Matthew Meyerson, Stacey Gabriel, Peter W Laird, David Haussler, Gad Getz, Lynda Chin. Cell 2013
Times Cited: 2395




List of shared articles



Times cited

RNA-sequencing of IDH-wild-type glioblastoma with chromothripsis identifies novel gene fusions with potential oncogenic properties.
Franck Ah-Pine, Déborah Casas, Philippe Menei, Blandine Boisselier, Emmanuel Garcion, Audrey Rousseau. Transl Oncol 2021
0

Human TERT promoter mutations as a prognostic biomarker in glioma.
Branka Powter, Sarah A Jeffreys, Heena Sareen, Adam Cooper, Daniel Brungs, Joseph Po, Tara Roberts, Eng-Siew Koh, Kieran F Scott, Mila Sajinovic,[...]. J Cancer Res Clin Oncol 2021
0

TERT Promoter Alterations in Glioblastoma: A Systematic Review.
Nathalie Olympios, Vianney Gilard, Florent Marguet, Florian Clatot, Frédéric Di Fiore, Maxime Fontanilles. Cancers (Basel) 2021
0

A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.
Nayuta Higa, Toshiaki Akahane, Seiya Yokoyama, Hajime Yonezawa, Hiroyuki Uchida, Tomoko Takajo, Mari Kirishima, Taiji Hamada, Kei Matsuo, Shingo Fujio,[...]. Cancer Sci 2020
2

Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma.
Radia M Johnson, Heidi S Phillips, Carlos Bais, Cameron W Brennan, Timothy F Cloughesy, Anneleen Daemen, Ulrich Herrlinger, Robert B Jenkins, Albert Lai, Christoph Mancao,[...]. Neuro Oncol 2020
5

Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma.
Maxime Fontanilles, Florent Marguet, Ludivine Beaussire, Nicolas Magne, Louis-Ferdinand Pépin, Cristina Alexandru, Isabelle Tennevet, Chantal Hanzen, Olivier Langlois, Fabrice Jardin,[...]. Acta Neuropathol Commun 2020
3

Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma.
Sirui Ma, Soumon Rudra, Jian L Campian, Sonika Dahiya, Gavin P Dunn, Tanner Johanns, Michael Goldstein, Albert H Kim, Jiayi Huang. Neurooncol Adv 2020
5

Beyond sequence variation: assessment of copy number variation in adult glioblastoma through targeted tumor somatic profiling.
Samantha N McNulty, Catherine E Cottrell, Katinka A Vigh-Conrad, Jamal H Carter, Jonathan W Heusel, George Ansstas, Sonika Dahiya. Hum Pathol 2019
13

Using germline variants to estimate glioma and subtype risks.
Jeanette E Eckel-Passow, Paul A Decker, Matt L Kosel, Thomas M Kollmeyer, Annette M Molinaro, Terri Rice, Alissa A Caron, Kristen L Drucker, Corinne E Praska, Melike Pekmezci,[...]. Neuro Oncol 2019
5